Mutant p53 as a Regulator and Target of Autophagy

Yong Shi1, Erik Norberg1, Helin Vakifahmetoglu-Norberg1

  • 1Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.

Frontiers in Oncology
|February 22, 2021
PubMed

Insights

Mutant tumor suppressor p53 (TP53) proteins gain new cancer-promoting functions, potentially by stimulating autophagy. Autophagy also targets mutant p53, offering cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • The tumor suppressor gene TP53 is frequently mutated in human cancers.
  • TP53 mutations often result in proteins with novel oncogenic functions, impacting cell metabolism and autophagy.
  • Autophagy, a crucial stress response, is frequently dysregulated in cancer, yet p53's role in its regulation is complex and not fully understood.

Purpose of the Study:

  • To review the role of distinct mutant p53 proteins in regulating various autophagic pathways.
  • To discuss evidence suggesting a potential autophagy-stimulatory role for mutant p53.
  • To explore how autophagy targets and degrades mutant p53, and potential therapeutic strategies.

Main Methods:

  • Literature review focusing on mutant p53 and autophagy.
  • Analysis of existing evidence on p53's complex role in autophagy.
  • Exploration of therapeutic strategies targeting mutant p53 via autophagy.

Main Results:

  • Mutant p53 proteins may possess distinct roles in regulating different autophagic pathways.
  • Evidence suggests that mutant p53 could potentially stimulate autophagy.
  • Autophagic pathways are involved in the degradation of mutant p53 proteins.

Conclusions:

  • Mutant p53 proteins can influence autophagy, with potential stimulatory effects.
  • Autophagy plays a role in degrading mutant p53, presenting therapeutic opportunities.
  • Targeting autophagy may be a viable strategy to combat cancers with mutant TP53.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.6K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.4K